Florida Tech Today
SEE OTHER BRANDS

News on science and technology in Florida

Florida Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Tech Today.

Press releases published on September 7, 2025

Veterans Cybersecurity Group Expands CMMC SkillBridge Program to Address Critical Assessor Shortage

Veterans Cybersecurity Group Expands CMMC SkillBridge Program to Address Critical Assessor Shortage

VCSG is actively seeking to partner with other DoD-approved SkillBridge providers who wish to offer a CMMC career track to their service members. PLANTATION, FL, UNITED STATES, September 7, 2025 /⁨EINPresswire.com⁩/ -- Veterans Cybersecurity Group Inc. ( …

DataGlobal Hub’s GDAI 2025 Showcases the World’s Brightest Minds in Data and AI

DataGlobal Hub’s GDAI 2025 Showcases the World’s Brightest Minds in Data and AI

PHOENIX, Sept. 07, 2025 (GLOBE NEWSWIRE) -- Global Data …

Dianthus Therapeutics to Host Conference Call and Webcast to Discuss Results from Phase 2 MaGic Trial of Claseprubart (DNTH103) in Generalized Myasthenia Gravis

Dianthus Therapeutics to Host Conference Call and Webcast to Discuss Results from Phase 2 MaGic Trial of Claseprubart (DNTH103) in Generalized Myasthenia Gravis

NEW YORK and WALTHAM, Mass., Sept. 07, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune …

Junshi Biosciences Announces the Phase 3 Study of JS005 (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis Met Primary Endpoints

Junshi Biosciences Announces the Phase 3 Study of JS005 (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis Met Primary Endpoints

SHANGHAI, Sept. 07, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel …

Un estudio sobre la genética del cáncer de pulmón lanza una plataforma de datos de código abierto para la comunidad investigadora

Un estudio sobre la genética del cáncer de pulmón lanza una plataforma de datos de código abierto para la comunidad investigadora

SAN FRANCISCO, Sept. 07, 2025 (GLOBE NEWSWIRE) -- El Instituto de Investigación 23andMe, Troper Wojcicki Philanthropies (TWP) y Lifebit han anunciado hoy el lanzamiento oficial de una plataforma de datos de código abierto para el Estudio genético sobre el …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions